Your browser doesn't support javascript.
loading
Autoimmune Bullous Skin Disorders with Immune Checkpoint Inhibitors Targeting PD-1 and PD-L1.
Naidoo, Jarushka; Schindler, Katja; Querfeld, Christiane; Busam, Klaus; Cunningham, Jane; Page, David B; Postow, Michael A; Weinstein, Alyona; Lucas, Anna Skripnik; Ciccolini, Kathryn T; Quigley, Elizabeth A; Lesokhin, Alexander M; Paik, Paul K; Chaft, Jamie E; Segal, Neil H; D'Angelo, Sandra P; Dickson, Mark A; Wolchok, Jedd D; Lacouture, Mario E.
Afiliação
  • Naidoo J; Department of Oncology, Sidney Kimmel Cancer Center at Johns Hopkins, Baltimore, Maryland. jnaidoo1@jhmi.edu.
  • Schindler K; Department of Dermatology and Dermato-oncology, Medical University of Vienna, Vienna General Hospital, Vienna, Austria.
  • Querfeld C; Department of Dermatology and Dermato-pathology, City of Hope Cancer Center and Beckman Research Institute, Duarte, California.
  • Busam K; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Cunningham J; Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Page DB; Department of Medicine, Portland Providence Medical Center, Earl A. Chiles Research Institute, Portland, Oregon.
  • Postow MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Weinstein A; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lucas AS; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Ciccolini KT; Department of Nursing, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Quigley EA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lesokhin AM; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Paik PK; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Chaft JE; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Segal NH; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • D'Angelo SP; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Dickson MA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York.
  • Wolchok JD; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. Ludwig Center for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lacouture ME; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. Weill Cornell Medical College, New York, New York. Department of Dermatology, Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer Immunol Res ; 4(5): 383-9, 2016 05.
Article em En | MEDLINE | ID: mdl-26928461
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Toxidermias / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Penfigoide Bolhoso / Toxidermias / Antígeno B7-H1 / Receptor de Morte Celular Programada 1 / Antineoplásicos Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2016 Tipo de documento: Article